Evidence map›Paper›PMID 26555042›Full record

ArticleACS chemical biology2016

Cytoplasmic Dynein Antagonists with Improved Potency and Isoform Selectivity.

Stephanie K See, Sascha Hoogendoorn, Andrew H Chung, Fan Ye, Jonathan B Steinman, Tomoyo Sakata-Kato, Rand M Miller, Tommaso Cupido, Ruta Zalyte, Andrew P Carter and 3 more

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Dynein 1 supports spermatid transport and spermiation during spermatogenesis in the rat testis.American journal of physiology. Endocrinology and metabolism · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Stephanie K See
Sascha Hoogendoorn
Andrew H Chung
Fan Ye
Jonathan B SteinmanLaboratory of Chemistry and Cell Biology, Rockefeller University , New York City, New York 10065, United States.
Tomoyo Sakata-Kato
Rand M MillerLaboratory of Chemistry and Cell Biology, Rockefeller University , New York City, New York 10065, United States.
Tommaso CupidoLaboratory of Chemistry and Cell Biology, Rockefeller University , New York City, New York 10065, United States.
Ruta ZalyteMedical Research Council Laboratory of Molecular Biology , Division of Structural Studies, Cambridge CB2 0QH, United Kingdom.
Andrew P CarterMedical Research Council Laboratory of Molecular Biology , Division of Structural Studies, Cambridge CB2 0QH, United Kingdom.
Maxence V Nachury
Tarun M KapoorLaboratory of Chemistry and Cell Biology, Rockefeller University , New York City, New York 10065, United States.
James K Chen
Rockefeller University · USMRC Laboratory of Molecular Biology · GB

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Quality control of the primary cilium proteomeR01GM089933 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Maxence V Nachury · 2010 to 2026
$5.8M
Studying chromosome function using chemical biologyR01GM098579 · NIGMS · ROCKEFELLER UNIVERSITY · PI KAPOOR, TARUN M. · 2011 to 2018
$3.3M
Hedgehog Pathway Blockade by Small-Molecule Gli AntagonistsR01CA136574 · NCI · STANFORD UNIVERSITY · PI CHEN, JAMES K · 2009 to 2013
$1.6M
Medical Research Council MC_UP_A025_1011NCI NIH HHS R01 CA136574NIGMS NIH HHS R01 GM089933NIGMS NIH HHS R01 GM098579NIGMS NIH HHS T32 GM007739Wellcome Trust 100387
6 · The paper itself

Abstract

Cytoplasmic dyneins 1 and 2 are related members of the AAA+ superfamily (ATPases associated with diverse cellular activities) that function as the predominant minus-end-directed microtubule motors in eukaryotic cells. Dynein 1 controls mitotic spindle assembly, organelle movement, axonal transport, and other cytosolic, microtubule-guided processes, whereas dynein 2 mediates retrograde trafficking within motile and primary cilia. Small-molecule inhibitors are important tools for investigating motor protein-dependent mechanisms, and ciliobrevins were recently discovered as the first dynein-specific chemical antagonists. Here, we demonstrate that ciliobrevins directly target the heavy chains of both dynein isoforms and explore the structure-activity landscape of these inhibitors in vitro and in cells. In addition to identifying chemical motifs that are essential for dynein blockade, we have discovered analogs with increased potency and dynein 2 selectivity. These antagonists effectively disrupt Hedgehog signaling, intraflagellar transport, and ciliogenesis, making them useful probes of these and other cytoplasmic dynein 2-dependent cellular processes.

Indexed as

AnimalsCytoplasmic DyneinsHedgehog ProteinsMiceMolecular StructureNIH 3T3 CellsProtein IsoformsQuinazolinonesSignal TransductionStructure-Activity RelationshipSubstrate SpecificityCytoplasmic DyneinsHedgehog ProteinsProtein IsoformsQuinazolinones

Identifiers

PMID26555042
PMCPMC4715766
OpenAlexW2237889577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.